Clinical approach to nonmotor sensory fluctuations in Parkinson's disease
暂无分享,去创建一个
[1] Copeman Pw,et al. PERIODIC BREATHING OF PREMATURE INFANTS. , 1964 .
[2] K. Chaudhuri,et al. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome , 1999, Acta neurologica Scandinavica.
[3] G. Schott. Pain in Parkinson's disease , 1985, Pain.
[4] C. Tanner,et al. Pain in Parkinson's disease , 1986, Movement disorders : official journal of the Movement Disorder Society.
[5] S. Factor,et al. Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[6] C. Marsden,et al. PAINFUL PARKINSON'S DISEASE , 1986, The Lancet.
[7] J. Burgunder,et al. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. , 2002, Journal of neurosurgery.
[8] C. Marsden,et al. LITHIUM FOR PAINFUL DYSTONIA IN PARKINSON'S DISEASE , 1986, The Lancet.
[9] N. Quinn. Classification of fluctuations in patients with Parkinson's disease , 1998, Neurology.
[10] R. Carasso,et al. Respiratory Muscle Performance and the Perception of Dyspnea in Parkinson's Disease , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[11] G. Linazasoro,et al. Nocturnal akathisia in parkinson's disease: Treatment with clozapine , 1993, Movement disorders : official journal of the Movement Disorder Society.
[12] W. Koller,et al. Sensory symptoms in Parkinson's disease , 1984, Neurology.
[13] W. Weiner,et al. Internal tremor in patients with Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.
[14] J. Sage. Pain in Parkinson’s disease , 2004, Current treatment options in neurology.
[15] J. Penney,et al. Striatal inhomogeneities and basal ganglia function , 1986, Movement disorders : official journal of the Movement Disorder Society.
[16] S. Fahn,et al. Oral and genital pain syndromes in Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.
[17] N. Tuncer,et al. The Clinical Profile of Nonmotor Fluctuations in Parkinson's Disease Patients , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[18] M. Cosio,et al. Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease. , 1989, Chest.
[19] A. Lang,et al. The spectrum of levodopa‐related fluctuations in Parkinson's disease , 1993, Neurology.
[20] P. Sonsalla,et al. Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug‐induced chorea , 1991, Annals of neurology.
[21] A. Benabid,et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[22] G. Nappi,et al. “Off” painful dystonia in Parkinson's disease treated with botulinum toxin , 1995, Movement disorders : official journal of the Movement Disorder Society.
[23] C. Honey,et al. Unilateral pallidotomy for reduction of parkinsonian pain. , 1999, Journal of neurosurgery.
[24] C. Goetz,et al. Akathisia in Parkinson's disease , 1994, Movement disorders : official journal of the Movement Disorder Society.
[25] F. Raudino. Non motor off in Parkinson's disease , 2001, Acta neurologica Scandinavica.
[26] G. Lopez,et al. Nonmotor fluctuations in Parkinson's disease: Clinical spectrum and classification , 2010, Journal of the Neurological Sciences.
[27] A. Lang,et al. Akathisia in idiopahic Parkinson's disease , 1987, Neurology.
[28] G. Wooten,et al. Progress in understanding the pathophysiology of treatment‐related fluctuations in Parkinson's disease , 1988 .
[29] W. Weiner,et al. Parkinson's Disease: Diagnosis and Clinical Management , 2007 .
[30] Mark Stacy,et al. Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment , 2005, Movement disorders : official journal of the Movement Disorder Society.
[31] L. Cote,et al. Primary sensory symptoms in parkinsonism , 1976, Neurology.
[32] Richard P Allen,et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. , 2003, Sleep medicine.
[33] A. Lees. A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease. , 1987, European neurology.
[34] A. Lees,et al. Baclofen in Parkinson's disease. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[35] M. Ceccaldi,et al. Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling , 2002, Neurology.
[36] Basic mechanisms of motor fluctuations. , 1994, Neurology.
[37] A J Lees,et al. Dopamine agonists in Parkinson's disease: a look at apomorphine , 1993, Fundamental & clinical pharmacology.
[38] Pattern of Non-Motor Fluctuations in Patients of Parkinson's Disease , 2009 .
[39] J. Sage,et al. Nonmotor fluctuations in patients with Parkinson's disease , 1996, Neurology.
[40] A L Benabid,et al. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. , 1999, Brain : a journal of neurology.